Rassy E - Search Results

1

Aberrations of DNA repair pathways in prostate cancer: a cornerstone of precision oncology.

Boussios S, Rassy E, Shah S, Ioannidou E, Sheriff M, Pavlidis N. Boussios S, et al. Among authors: rassy e. Expert Opin Ther Targets. 2021 May;25(5):329-333. doi: 10.1080/14728222.2021.1951226. Epub 2021 Jul 8. Expert Opin Ther Targets. 2021. PMID: 34225539 No abstract available.

2

Pattern and risk factors of isolated local relapse among women with hormone receptor-positive and HER2-negative breast cancer and lymph node involvement: 10-year follow-up analysis of the PACS 01 and PACS 04 trials.

Rassy E, Filleron T, Viansone A, Lacroix-Triki M, Rivera S, Desmoulins I, Serin D, Canon JL, Campone M, Gonçalves A, Levy C, Cottu P, Petit T, Eymard JC, Debled M, Bachelot T, Dalenc F, Roca L, Lemonnier J, Delaloge S, Pistilli B. Rassy E, et al. Breast Cancer Res Treat. 2023 Jun;199(2):371-379. doi: 10.1007/s10549-023-06912-4. Epub 2023 Mar 29. Breast Cancer Res Treat. 2023. PMID: 36988749

3

A comprehensive review of the role of immune checkpoint inhibitors in brain metastasis of renal cell carcinoma origin.

Kattan J, Rassy EE, Assi T, Bakouny Z, Pavlidis N. Kattan J, et al. Crit Rev Oncol Hematol. 2018 Oct;130:60-69. doi: 10.1016/j.critrevonc.2018.08.001. Epub 2018 Aug 7. Crit Rev Oncol Hematol. 2018. PMID: 30196913 Review.

4

Cancer of unknown primary: Incidence rates, risk factors and survival among adolescents and young adults.

Pavlidis N, Rassy E, Smith-Gagen J. Pavlidis N, et al. Among authors: rassy e. Int J Cancer. 2020 Mar 15;146(6):1490-1498. doi: 10.1002/ijc.32482. Epub 2019 Jun 25. Int J Cancer. 2020. PMID: 31144291 Free article.

5

The interaction of immune checkpoint inhibitor plus chemotherapy in non-small-cell lung cancer: subadditivity, additivity or synergism?

Rassy E, Bakouny Z, Assi T, Karak FE, Pavlidis N. Rassy E, et al. Immunotherapy. 2019 Jul;11(10):913-920. doi: 10.2217/imt-2019-0014. Epub 2019 Jun 12. Immunotherapy. 2019. PMID: 31188048 Review.

6

Familial cancer of unknown primary.

Rassy E, Kattan J, Pavlidis N. Rassy E, et al. Int J Clin Oncol. 2019 Oct;24(10):1328-1331. doi: 10.1007/s10147-019-01491-1. Epub 2019 Jun 15. Int J Clin Oncol. 2019. PMID: 31203526

7

The currently declining incidence of cancer of unknown primary.

Rassy E, Pavlidis N. Rassy E, et al. Cancer Epidemiol. 2019 Aug;61:139-141. doi: 10.1016/j.canep.2019.06.006. Epub 2019 Jun 26. Cancer Epidemiol. 2019. PMID: 31254795

8

Comprehensive management of HPV-related squamous cell carcinoma of the head and neck of unknown primary.

Rassy E, Nicolai P, Pavlidis N. Rassy E, et al. Head Neck. 2019 Oct;41(10):3700-3711. doi: 10.1002/hed.25858. Epub 2019 Jul 13. Head Neck. 2019. PMID: 31301162 Review.

9

Combined Strategies with Poly (ADP-Ribose) Polymerase (PARP) Inhibitors for the Treatment of Ovarian Cancer: A Literature Review.

Boussios S, Karihtala P, Moschetta M, Karathanasi A, Sadauskaite A, Rassy E, Pavlidis N. Boussios S, et al. Among authors: rassy e. Diagnostics (Basel). 2019 Aug 1;9(3):87. doi: 10.3390/diagnostics9030087. Diagnostics (Basel). 2019. PMID: 31374917 Free PMC article. Review.

10

Advances in the management of brain metastases from cancer of unknown primary.

Rassy E, Zanaty M, Azoury F, Pavlidis N. Rassy E, et al. Future Oncol. 2019 Aug;15(23):2759-2768. doi: 10.2217/fon-2019-0108. Epub 2019 Aug 6. Future Oncol. 2019. PMID: 31385529 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

201 results

Search Page